Stopping lopinavir/ritonavir in COVID-19 patients : duration of the drug interacting effect
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:75 |
|---|---|
| Enthalten in: |
The Journal of antimicrobial chemotherapy - 75(2020), 10 vom: 01. Okt., Seite 3084-3086 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Stader, Felix [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
2494G1JF75 |
|---|
| Anmerkungen: |
Date Completed 29.09.2020 Date Revised 10.01.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/jac/dkaa253 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM311349633 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM311349633 | ||
| 003 | DE-627 | ||
| 005 | 20231225142048.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/jac/dkaa253 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1037.xml |
| 035 | |a (DE-627)NLM311349633 | ||
| 035 | |a (NLM)32556272 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Stader, Felix |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Stopping lopinavir/ritonavir in COVID-19 patients |b duration of the drug interacting effect |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.09.2020 | ||
| 500 | |a Date Revised 10.01.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Cytochrome P-450 CYP3A Inhibitors |2 NLM | |
| 650 | 7 | |a Lopinavir |2 NLM | |
| 650 | 7 | |a 2494G1JF75 |2 NLM | |
| 650 | 7 | |a Ritonavir |2 NLM | |
| 650 | 7 | |a O3J8G9O825 |2 NLM | |
| 700 | 1 | |a Khoo, Saye |e verfasserin |4 aut | |
| 700 | 1 | |a Stoeckle, Marcel |e verfasserin |4 aut | |
| 700 | 1 | |a Back, David |e verfasserin |4 aut | |
| 700 | 1 | |a Hirsch, Hans H |e verfasserin |4 aut | |
| 700 | 1 | |a Battegay, Manuel |e verfasserin |4 aut | |
| 700 | 1 | |a Marzolini, Catia |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of antimicrobial chemotherapy |d 1981 |g 75(2020), 10 vom: 01. Okt., Seite 3084-3086 |w (DE-627)NLM000017701 |x 1460-2091 |7 nnns |
| 773 | 1 | 8 | |g volume:75 |g year:2020 |g number:10 |g day:01 |g month:10 |g pages:3084-3086 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/jac/dkaa253 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 75 |j 2020 |e 10 |b 01 |c 10 |h 3084-3086 | ||